A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Geoffrey ShouseLu ChenTanya SiddiqiAlex MuirJennifer R BrownStephen E SpurgeonAlexey V DanilovPublished in: Leukemia & lymphoma (2024)